Abstract
Patients in inpatient rehabilitation for uncomplicated cocaine dependence were asked whether, compared with the time of their first regular use, they could now identify changes in the effects of similar doses of cocaine. We asked about a spectrum of cocaine effects “then” and “now” and whether the same amount of drug caused effects to occur to about the same degree, less intensely (tolerance), or more intensely (sensitization). Nearly half our sample developed predominantly paranoid psychoses in the context of cocaine use. Sensitization was consistently linked only to psychosis-related cocaine effects.
It has been proposed that mesolimbic dopaminergic sensitization might contribute to addiction severity. A preliminary followup of patients who were sensitized or nonsensitized to psychosis development suggests that rehospitalization for treatment of addiction may be more frequent in the sensitized group.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bartlett, E., Hallin, A., Chapman, B. et al. Selective Sensitization to the Psychosis-Inducing Effects of Cocaine: A Possible Marker for Addiction Relapse Vulnerability?. Neuropsychopharmacol 16, 77–82 (1997). https://doi.org/10.1016/S0893-133X(96)00164-9
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/S0893-133X(96)00164-9
Keywords
This article is cited by
-
Dopamine cross-sensitization between psychostimulant drugs and stress in healthy male volunteers
Translational Psychiatry (2016)
-
Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?
BMC Psychiatry (2012)
-
Methamphetamine-induced changes in the striatal dopamine pathway in μ-opioid receptor knockout mice
Journal of Biomedical Science (2011)
-
Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90)
Annals of General Psychiatry (2010)
-
A neurocognitive animal model dissociating between acute illness and remission periods of schizophrenia
Psychopharmacology (2009)